Brainstem intraparenchymal clear cell meningioma
disease diseaseOn this page
Also known as brain stem intraparenchymal clear cell meningiomaintraparenchymal clear cell meningioma of brainstemintraparenchymal clear cell meningioma of the brainstem
Summary
Brainstem intraparenchymal clear cell meningioma (MONDO:0002916) is a disease. A subtype of clear cell meningioma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | brainstem intraparenchymal clear cell meningioma |
| Mondo ID | MONDO:0002916 |
| DOID | DOID:4209 |
| NCIT | C5295 |
| UMLS | C1332612 |
| MedGen | 231959 |
| GARD | 0023298 |
| Is cancer (heuristic) | no |
Also known as: brain stem intraparenchymal clear cell meningioma · intraparenchymal clear cell meningioma of brainstem · intraparenchymal clear cell meningioma of the brainstem
Disease family
This is a subtype of clear cell meningioma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › nervous system disorder › central nervous system disorder › central nervous system neoplasm › tumor of meninges › meningioma › clear cell meningioma › brainstem intraparenchymal clear cell meningioma
Related subtypes (1): spinal multifocal clear cell meningioma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.